“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart
Article: P.04 HDAC in Chronic Lymphocytic Leukaemia: expression profile, enzymatic activity and prognostic significance
P.04 HDAC in Chronic Lymphocytic Leukaemia: expression profile, enzymatic activity and prognostic significance
Reviews
There are no reviews yet.
Be the first to review “Article: P.04 HDAC in Chronic Lymphocytic Leukaemia: expression profile, enzymatic activity and prognostic significance” Cancel reply
Reviews
There are no reviews yet.